|
Menopause is a normal biological event that marks the end of a woman's
reproductive years. It is the point when menstruation stops permanently. On
average, menopause occurs at age 51, but like the beginning of menstruation in
adolescence, timing varies from person to person. Today, an estimated 50 million
women in the United States have reached menopause and most women will spend at
least one-third of their lives in or beyond menopause.
Menopause is the last stage of a gradual biological process in which the
ovaries reduce their production of female sex hormones. Estrogen production in
the body diminishes slowly over a period of years, commonly resulting in hot
flashes, night sweats, mood swings, and memory loss. This gradual phase before
the permanent cessation of menstrual periods is sometimes called perimenopause.
The process of menopause is considered complete when a woman has not menstruated
for an entire year. Another type of menopause, known as surgical menopause,
occurs if both ovaries are removed for medical reasons. This may be done at the
time of a hysterectomy (removal of the uterus).
Living without the protective effects of estrogen increases a woman's risk
for developing serious medical conditions, including osteoporosis and
cardiovascular disease. There are a variety of treatments available, however, to
help ease the symptoms of and reduce health risks associated with
menopause.
|
|
|
| Signs and Symptoms |
|
|
Each woman experiences her own variation of the typical symptoms of
menopause. Some studies even suggest that the signs and symptoms of menopause
may vary between cultural groups. For example, up to 80% of American women
experience hot flashes during menopause while only 10% of Japanese women
experience that symptom. Some researchers speculate that these differences may
be due to differences in diet, lifestyle, and/or cultural attitudes toward
aging.
In general, however, the loss of estrogen that occurs during menopause causes
the following symptoms:
- Irregular menstrual cycles—menstrual bleeding
slows, becomes erratic, and then stops permanently (the process takes about 4
years)
- Hot flashes—flushing of face and chest (may
be accompanied by heart palpitations, dizziness, headaches)
- Night sweats
- Cold hands and feet
- Vaginal changes—dryness, itching, bleeding
after intercourse
- Urinary changes—frequent urination, burning
during urination, urinating at night, incontinence
- Insomnia
- Mood changes—depression, irritability,
tension (usually occurs with sleep disturbances)
- Loss of skin tone leading to wrinkles
- Weight gain and change in weight distribution with increased fat in
the central, abdominal area
Over time, depleted estrogen levels can contribute to the development of more
serious medical conditions, including the following:
- Osteoporosis
- Cardiovascular disease
- Alzheimer's disease
- Macular degeneration (a serious eye disorder and the leading cause of
blindness in the Western world)
- Glaucoma
- Colon cancer
|
|
|
| Causes |
|
|
Menopause is caused by a gradual reduction in the amount of estrogen produced
in the ovaries. Estrogen, a female hormone produced primarily by the ovaries, is
essential for the reproductive process and influences menstrual cycles,
pregnancy, some aspects of mood, and the aging process. In the years leading up
to menopause, the ovaries become less functional and produce lower amounts of
estrogen and progesterone (another female hormone). Studies indicate that women
who smoke may reach menopause at a younger age than those who do not smoke. Some
researchers speculate that the timing of menopause onset may be hereditary, but
the evidence to support this claim is limited.
Although menopause usually occurs naturally, it can be artificially induced
through surgical removal of the ovaries (this is called surgical menopause).
Menopause can also be caused by ovarian failure from cancer therapy, such as
chemotherapy or radiation treatments.
|
|
|
| Risk Factors |
|
|
Menopause is part of the natural aging process in all women, unless it is
caused by surgical removal of both ovaries. (This operation, known as a
bilateral oopherectomy, may be performed at the time of a hysterectomy).
Surgical menopause tends to cause a more abrupt onset of symptoms. The following
risk factors may also hasten the onset of menopausal symptoms:
- Radiation, and/or chemotherapy
- Premature ovarian failure
- Smoking
- Hypothyroidism—diminished production of
thyroid hormone
- Insufficient production of hormones by the adrenal
glands
|
|
|
| Diagnosis |
|
|
In general, menopause is considered complete when a woman has not menstruated
for at least 1 year. A healthcare provider will perform an examination that
includes a Pap smear, blood tests looking at hormone and cholesterol levels,
and, possibly, a bone density measurement. It is important to have a thorough
discussion with the healthcare provider regarding the benefits and risks of
different options for reducing symptoms and health risks. If vaginal bleeding
resumes unexpectedly once menopause has occurred, your doctor may consider a
test called an endometrial biopsy. In this test (performed in the office), a
gynecologist takes a sample of the uterine lining (the endometrium) and examines
them under the microscope for abnormal changes.
|
|
|
| Preventive Care |
|
|
The following preventive measures may help diminish symptoms and reduce the
risk of serious complications (such as osteoporosis and cardiovascular disease)
associated with menopause:
- Quitting smoking—smokers tend to begin
menopause 1 to 2 years earlier than nonsmokers; smokers are also at an increased
risk for heart disease and osteoporosis
- Taking
calcium
supplements—helps protect against bone
loss
-
Exercising—slows
the rate of bone loss, reduces hot flashes, and improves mood
- Consuming low-fat
diets—helps
prevent cardiovascular disease by decreasing LDL "bad" cholesterol and by
lowering the chances of weight gain
- Taking certain
medications (such as estrogen or
non-hormonal medications)—prevents long-term illnesses
associated with menopause, such as osteoporosis
- Avoiding caffeine—some studies suggest that
caffeine consumption may be a risk factor for osteoporosis in postmenopausal
women
|
|
|
| Treatment Approach |
|
|
The goal in treating menopause is to alleviate symptoms and reduce the risk
for long-term medical conditions, such as heart disease, breast cancer, and
osteoporosis. There are a variety of treatment options available to menopausal
women. To help determine the most appropriate treatment, it is important for
each woman to discuss personal risks and benefits with her healthcare provider.
To combat symptoms and prevent the development of osteoporosis associated
with diminished estrogen levels, many healthcare practitioners recommend
hormone replacement therapy (HRT). HRT
involves the administration of the female sex hormones, estrogen and
progesterone. Estrogen replacement therapy (ERT) refers to the administration of
estrogen alone. ERT has proven to be very effective in relieving many of the
symptoms of menopause, and is also thought to help prevent osteoporosis and,
possibly, heart disease. Hormone treatment for menopause is still quite
controversial, however, especially as it relates to treatment for heart disease.
Also of particular concern is the possibility that women taking ERT are at an
increased risk for breast cancer. Based on these concerns and scientific
evidence to date, physicians are unable to recommend HRT for all women. There
are no right or wrong answers to the question of whether or not to use HRT. Each
woman must weigh the possibilities based on individual symptoms and risks for
other medical conditions such as osteoporosis and cardiovascular disease.
For some women, other medications and non-drug therapies may be the only
reasonable choice. The following remedies have been shown to reduce the risk for
long-term medical conditions associated with menopause:
Other remedies that may help alleviate the symptoms of menopause include
magnesium,
black cohosh,
acupuncture, and relaxation
techniques.
|
|
|
| Lifestyle |
|
|
Exercise
The benefits of exercise include:
- Slowing the rate of bone loss (through weight-bearing exercises)
- Reducing hot flashes
- Boosting mood
- Enhancing memory and concentration
- Improving cholesterol
- Improving pelvic muscle tone through Kegel exercises
- Maintenance of general health and strength, particularly for elderly
who are better able to maintain independence if they exercise
Diet
The right diet can help a woman battle many of the risks and discomforts
associated with menopause. A low-fat, low-cholesterol diet, for example, may
diminish the risk of heart disease in menopausal women by providing the
following benefits:
- Less of a rise in LDL cholesterol and triglycerides (both are bad
forms of cholesterol)
- At least short-term lowering of blood pressure
- Diminished weight gain
In addition,
soy-based foods like tofu have been
shown to help minimize certain symptoms of menopause, including hot flashes.
Adding plenty of
calcium to the diet can also help a
menopausal women avoid bone loss. (Foods rich in calcium include dairy products,
leafy green vegetables, almonds, and dried beans). High fiber meals may also
help lower a woman's risk of high cholesterol and heart disease.
|
|
|
| Medications |
|
|
There are many medications available in the form of natural and synthetic
hormones (estrogen and progesterone) to treat symptoms of menopause. Commonly
referred to as hormone replacement therapy (HRT), these medications are usually
administered in pill form, although skin patches and vaginal creams may also be
used.
Unfortunately, hormone treatment for menopause is still quite controversial.
Many women find the conflicting information regarding whether or not to take
hormones confusing, even frustrating. In fact, according to the National
Institutes of Health, only about 15 percent of women who are eligible for HRT
are now receiving it. This means that 85 percent of American women have either
not been told about this option or they choose not to take HRT. The following
information represents a summary of the most commonly used hormone medications.
A woman and her healthcare provider can discuss the pros and cons of all
treatment options to determine which approach is most appropriate.
Estrogen
Estrogen replacement therapy (ERT) refers to the
administration of the female sex hormone, estrogen. In addition to reducing the
symptoms of menopause, ERT is thought to help prevent the devastating effects of
osteoporosis and reduce risk factors associated with heart disease, particularly
bad cholesterol. Most studies showing long-term beneficial effects for ERT have
examined this hormone alone.
The decision regarding whether to take estrogen depends on several factors
including a woman's risk for cardiovascular disease, breast cancer, and
osteoporosis, as well as the severity of her menopausal symptoms.
Studies indicate that estrogen helps to reduce hot flashes and vaginal
dryness. It can also slow bone loss thereby minimizing fractures associated with
osteoporosis, and improve cholesterol levels. Women who take estrogen appear to
be at lower risk for Alzheimer's disease, colon cancer, and macular
degeneration. Estrogen may also prevent heart disease in women who have never
had the condition, but women who already have heart disease do not appear to
share that benefit.
Despite these potential advantages, some studies indicate that estrogen
increases the risk of developing breast cancer, gallbladder disease, asthma,
liver disease, blood clots and, if used without progesterone, uterine cancer.
Side effects of estrogen use include bloating, nausea, and breast
tenderness.
Estrogen is available in a variety of
forms—estradiol is considered the strongest form and
estropipate the weakest. Mixtures of estrogens (also known as conjugated
estrogens) are also often prescribed.
Estrogens (or estrogen derivatives)
- Conjugated equine estrogens—available as
tablet, cream, or injection
- Conjugated synthetic
estrogens—tablet
- Dienestrol—vaginal cream
- Esterified estrogens—tablet
- Estradiol—tablet, cream, transdermal patch,
vaginal ring, or injection
- Estriol—a weak estrogen; available in Europe
in oral, topical, or vaginal gel forms; made in compounding pharmacies in the
United States as tablet, capsule, or gel that include 10% estradiol, 10%
estrone, and 80% estriol; serum levels of estradiol and estrone should be
followed and the dosage adjusted if levels fall outside the therapeutic
range
- Estropipate—tablet, cream
- Ethinyl estradiol—tablet
Progesterone
Estrogen stimulates the growth of the inner lining of the uterus
(endometrium); it is the endometrium that sheds during menstruation. ERT used
after menopause can also stimulate endometrium growth, but this growth may occur
uncontrollably and even result in cancer. Progesterone counteracts this
dangerous effect on the uterus and reduces the risk of developing uterine cancer
by causing monthly shedding of the endometrium. Therefore, when a menopausal
woman has not had a hysterectomy (has an intact uterus), progesterone is used in
combination with estrogen.
In rare instances, progesterone may be used without estrogen to treat hot
flashes and other symptoms of menopause. Generally, however, most physicians
recommend that women who have a uterus use a combination of estrogen and
progesterone to combat symptoms of menopause and reduce the risk of uterine
cancer. Progesterone is available in synthetic forms (progestins) and natural
forms. Natural progesterones appear to cause fewer side effects than synthetic
progesterones.
Progesterones frequently prescribed include:
- Medroxyprogesterone acetate—tablet or
injection
- Norethindrone acetate—tablet
- Micronized progesterone—tablet, cream, or
suppository
Combination Therapy
Combinations of estrogen and progesterone in a single pill may be prescribed
to make the daily treatment regimen easier.
Common combination prescriptions include:
- Conjugated estrogens and
medroxyprogesterone—tablet�
- Estradiol and norethindrone—tablet or patch
- Estradiol and micronized
progesterone—tablet�
Testosterone
Although generally considered a male hormone, testosterone may be prescribed
to a woman in small amounts in combination with estrogen. Testosterone appears
to improve bone mass, sexual drive, and mental alertness. Side effects of this
therapy include increased body hair, acne, fluid retention, anxiety, and
depression. The long-term risks of testosterone are not well known at this
time.
Common prescriptions with testosterone include:
- Estrogen Esterified and Testosterone
Selective Estrogen-Receptor Modulators (SERMs)
A woman who either cannot or who chooses not to take estrogen may be advised
to try a class of drugs called selective estrogen-receptor modulators (SERMs).
Raloxifene, the main drug in this category used for menopause, helps to prevent
osteoporosis without increasing a woman's risk of developing breast or uterine
cancer. These medications do not improve symptoms of menopause, however, and may
even make those symptoms worse.
|
Bisphosphonates
Another class of medications, the biphosphonates, is used primarily for women
with early signs of bone loss or osteoporosis, and cannot take hormones.
Alendronate, one type of biphosphonate, helps to build bone mass, particularly
once osteoporosis has set in.
|
|
|
|
| Nutrition and Dietary Supplements |
|
|
Soy
Soy foods contain plant-based estrogens (phytoestrogens) called isoflavones
that appear to reduce hot flashes, improve cholesterol, and may decrease bone
loss. The North American Menopause Society (NAMS) recommends including soy foods
in the diet, rather than soy supplements or other substances with
phytoestrogens, to help reduce menopausal symptoms. However, researchers are
still working to determine whether soy increases or decreases a woman's risk of
developing either breast or uterine cancer.
Flaxseed
Flaxseed contains omega-3 fatty acids and plant-based estrogens
(phytoestrogens) called lignans that may help reduce symptoms of menopause,
protect against breast cancer, and prevent heart disease. More research is
needed to determine the connection between the use of flaxseed and breast cancer
in particular.
Calcium
The National Institutes of Health (NIH) and NAMS recommends that
postmenopausal women consume between 1,000 and 1,500 milligrams of calcium per
day to boost bone mass. Some studies suggest that calcium may be particularly
effective when combined with ERT. Foods rich in calcium include dairy, green
leafy vegetables, black strap molasses, almonds, and dried beans. If adequate
amounts of calcium are not being obtained through the diet, calcium supplements
may be necessary. Calcium is available in many forms, but one in
particular—calcium
citrate—appears to be more easily absorbed from the
intestinal tract than other forms.
Vitamin D
Vitamin D, along with calcium, is essential for building and maintaining
healthy bones throughout life. In fact, calcium can be absorbed into the body
only when vitamin D is present. As levels of vitamin D diminish with age,
calcium deficiencies can arise, increasing the risk for osteoporosis and bone
fractures. The recommended dietary intake for vitamin D is currently 400 IU per
day for women between the ages of 50 and 70 years and 600 IU for those older
than age 70. Sources of this vitamin include sunlight, fatty fish, dairy
fortified with vitamin D, and supplements. Most women can meet their vitamin D
needs with moderate exposure to the sun and with supplements.
Magnesium
Magnesium helps the body absorb calcium. These two nutrients should be taken
together in a 2:1 ratio, calcium: magnesium (for example, 1,000 to 1,500
milligrams of calcium and 500 to 750 milligrams of magnesium per day). In
addition, as estrogen levels drop during menopause, magnesium levels seem to
diminish as well. For this reason, magnesium may also help to relieve some
menopausal symptoms such as hot flashes. More research is needed. Rich sources
of magnesium include tofu, nuts (particularly Brazil nuts, almonds, cashews,
black walnuts, and pine nuts), pumpkin and squash seeds, peanuts and other
legumes, green leafy vegetables, wheat germ, soy bean flour, and black strap
molasses.
Boron
Boron assists in the proper metabolism (processing by the body) of magnesium.
Studies suggest that 1 to 3 milligrams of boron per day is needed to maintain
normal levels of magnesium. If normal levels of magnesium are not present, the
body is less able to absorb calcium. Menopausal women who take boron
supplements, therefore, can boost levels of calcium in their blood, which helps
prevent bone loss. Generally, however, adequate amounts of boron can be obtained
through foods such as vegetables, nuts, and legumes.
Vitamin K
Studies suggest that 45 milligrams of vitamin K per day may help prevent bone
loss. Vitamin K can be found in green tea, turnip greens, broccoli, spinach,
cabbage, asparagus, and dark green lettuce. Because this vitamin, in both
supplement and dietary forms, helps blood to clot, it must not be consumed by
those taking blood-thinning medications, such as warfarin.
Omega-3 Fatty Acids
Preliminary studies indicate that omega-3 fatty acids (in the form of fish
oil or flaxseed) help to improve cholesterol levels and decrease the risk of
heart disease.
Antioxidants
Antioxidants, such as vitamins C and E, may help women avoid serious medical
conditions associated with menopause. For example, studies have shown that over
the long term (10 years or more), 250 to 500 milligrams of vitamin C taken one
to two times per day decreases the risk of heart disease and increases bone
mass. In addition, 400 to 800 IU of vitamin E per day lowers the risk of heart
disease and, possibly, other age-related illnesses such as Alzheimer's disease
and macular degeneration. Large population studies also strongly suggest that
intake of food sources of vitamin E (such as wheat germ, nuts [particularly
walnuts, almonds, and hazelnuts], vegetable oil [including canola, corn,
soybean, and safflower], spinach, kale, sweet potatoes, and yams) also decreases
the risk of a stroke after menopause.
|
|
|
| Herbs |
|
|
The information available to date suggests that menopausal symptoms may be
alleviated for some women by using herbs, particularly black cohosh. Symptom
improvement is different for each woman, however—some
women have a noticeable improvement in symptoms such as hot flashes, mood
swings, and insomnia, while others notice no change or only experience relief
for a short period of time.
Black cohosh (Cimicifuga racemosa)
Black cohosh is used to relieve symptoms of menopause including hot flashes,
irritability, mood swings, and feelings of depression. This herb is considered a
safe and effective alternative to estrogen when hormones cannot be used.
Dong quai (Angelica sinensis)
Dong quai, in combination with other herbs,�has been used for
thousands of years in Traditional Chinese Medicine to relieve symptoms of
menopause. While there continue to be reports of improvement in symptoms using
this herb, the effect of using dong quai by itself varies from woman to woman.
Clinical studies comparing dong quai only to a placebo do not confirm a specific
benefit of this herb. In general, however, dong quai is thought to be safe for
relief of menopausal symptoms, particularly if hormones cannot be used.
Red clover (Trifolium pratense)
Red clover contains high quantities of plant-based estrogens called
isoflavones that may improve menopausal symptoms, reduce the risk of bone loss,
and lower the risk of heart disease by improving blood pressure and possibly by
increasing HDL cholesterol (the "good" kind of cholesterol).
Asian ginseng (Panax ginseng)
Asian ginseng may be used by menopausal women to reduce stress, improve
general well-being, decrease feelings of depression, and enhance memory. This
herb is thought to have estrogen-like activities, although not all studies
support this assertion.
Wild yam (Dioscorea villosa)
Many women claim that wild yam (when used as a cream) improves menopausal
symptoms, particularly vaginal dryness. While this extract has been converted to
progesterone in laboratory test tubes, the value of wild yam for menopausal
symptoms has not yet been fully evaluated in people or even in animals.
Evening primrose (Oenothera biennis)
Some women report that evening primrose oil diminishes the frequency and
intensity of their hot flashes, but these claims have not been proven by
scientific studies.
Although the following herbs have not been investigated in clinical studies,
a professional herbalist will carefully evaluate an individual woman and may
consider prescribing one or more of the following to alleviate symptoms of
menopause:
- Licorice (Glycyrrhiza glabra)
- Stinging nettle (Urtica dioca)
- Saw palmetto (Serenoa repens)
- Uva ursi (Arctostaphylos uva ursi)
- Valerian root (Valeriana officinalis)
- Angelica root (Angelica archangelica);�Purplestem
angelica (Angelica atropurpurea)
|
|
|
| Acupuncture |
|
|
Acupuncture enhances the release of endorphins (opiate-like hormones), and
preliminary studies suggest that it may improve mood, including feelings of
sadness and fear, in menopausal women. It may also help to balance hormones and
relieve hot flashes.
|
|
|
| Massage and Physical Therapy |
|
|
Stress reduction is an important aspect of living with menopause. Massage may
reduce stress and promote healthy circulation and general relaxation.
|
|
|
| Homeopathy |
|
|
Although homeopathic remedies have not been studied for menopause, a licensed
and certified homeopath might consider one or more of the following remedies to
help ease symptoms:
-
Lachesis (venom of the bushmaster)—hot
flashes, irritability
-
Sepia (cuttlefish)—low energy, mood
swings, vaginal dryness, irritability
-
Pulsatilla (windflower)—mood swings,
insomnia
-
Sulfur (sulfur)—hot flashes,
irritability
-
Lycopodium (club moss)—bloating,
flatulence, pain with intercourse
-
Argentum nitricum (silver
nitrate)—anxiety, nervousness, irritability,
insomnia
-
Calcarea phosphorica (calcium
phosphate)—improves bone density
-
Belladonna (deadly nightshade)—hot
flashes, especially if they begin abruptly
A homeopathic doctor considers many different aspects of an individual before
a particular prescription is chosen. Women considering using a homeopathic
remedy should be evaluated and treated by a well-trained homeopath.
Mind/Body Medicine�
Some studies suggest that learning to relax the body (through paced
respiration, or slow, deep breathing) may reduce the intensity of hot
flashes.
|
|
|
| Traditional Chinese Medicine |
|
|
In Traditional Chinese Medicine, or TCM, a woman is not generally referred to
as "menopausal." Rather, a practitioner of TCM might say that she exhibits
"kidney yin deficiency." TCM is based, in part, on a belief in yin and
yang—defined as opposing energies, such as earth and
heaven, winter and summer, and happiness and sadness. The focus of TCM, like
many other alternative therapies, is to maintain balance and prevent illness.
Therefore, a TCM practitioner would attempt to restore balance in the case of a
"kidney yin deficiency" by boosting kidney energy. This is done with a
combination of acupuncture, herbs, and other methods of treatment (specific
diagnoses and treatments vary from woman to woman). Menopausal women in China
report improvement in mood swings, irritability, anxiety, tension, and
depression from TCM remedies, particularly
acupuncture.�
|
|
|
| Other Considerations |
|
|
| Prognosis and Complications |
|
|
As estrogen levels diminish during menopause, a woman's risk of developing
the following medical conditions may increase:
- Cardiovascular disease
- Osteoporosis
- Alzheimer's disease
- Macular degeneration (a serious eye disorder and the leading cause of
blindness in the Western world)
- Glaucoma
- Colon cancer
Menopause is part of the natural aging process for all women. There are many
therapies available, however, to help ease the symptoms of and reduce health
risks associated with menopause. Selecting the appropriate treatment, whether
medications, TCM, herbal remedies, or lifestyle changes, can minimize discomfort
and maximize the opportunities for a vital, healthy, satisfying life during and
after menopause.
|
|
|
| Supporting Research |
|
|
Albertazzi P, Pansini F, Bonaccorsi G, et al. The effect of dietary soy
supplementation on hot flushes. Obstet Gynecol. 1998;91:6-11.
Alekel DL, St. Germain A, Peterson CT, et al. Isoflavone-rich soy protein
isolate attentuates bone loss in the lumbar spine of perimenopausal women. Am
J Clin Nutr 2000;72:844-852.
Alexandersen P, Toussaint A, Christiansen C, et al. Ipriflavone in the
treatment of postmenopausal osteoporosis: A randomized controlled trial.
JAMA. 2001;285(11):1482-1488.
Baeksgaard L, Andersen KP, and Hyldstrup L. Calcium and vitamin D
supplementation increases spinal BMD in healthy, postmenopausal women.
Osteoporos Int. 1998;8:255-260.
Barnabei VM, Phillips, TM, Hsia J. Plasma homocysteine in women taking
hormone replacement therapy: the Postemenopausal Estrogen/Progestin
Interventions (PEPI) Trial. J Womens Health Gend Based Med.
1999;8(9):1167-1172.
Barnhart KT, Freeman E, Grisso JA. The effect of dehydroepiandrosterone
supplementation to symptomatic perimenopausal women on serum endocrine profiles,
lipid parameters, and health-related quality of life. J Clin Endocrinol
Metab 1999;84:3896-3902.
Bittner V. Hormone replacement therapy in clinical cardiology. Cardiol
Rev. 2000;8(1):57-64.
Brincat MP. Hormone replacement therapy and the skin. Maturitas.
2000;35(2):107-117.
Brzezinski A. "Melatonin replacement therapy" for postmenopausal women: is it
justified? Menopause. 1998;5:60-64.
Bush TL. Preserving cardiovascular benefits of hormone replacement therapy.
J Reprod Med. 2000;45(3Suppl):259-273.
Carr BR, Bradshaw KD. Disorders of the ovary and female reproductive tract.
In: Fauci A, Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles
of Internal Medicine. New York: McGraw Hill.;1998:2102-2106.
Chenoy R, Hussain S, Tayob Y, et al. Effect of oral gamolenic acid from
evening primrose oil on menopausal flushing. BMJ. 1994;308:501-503.
Contreras I, Parra D. Estrogen replacement therapy and the prevention of
coronary heart disease in postmenopausal women. Am J Health Syst Pharm.
2000;57(21):1963-1971.
Duker E-M, Kopanski L, Jarry H, et al. Effects of extracts from Cimcifuga
racemosa on gonadotropin release in menopausal women and ovariectomized
rats. Planta Med. 1991; 57:420-424.
Fardellone P, Brazier M, Kamel S, et al. Biochemical effects of calcium
supplementation in postmenopausal women: influence of dietary calcium intake.
Am J Clin Nutr. 1998;67:1273-1278.
Freedman RR, Woodward S. Behavioral treatment of menopausal hot flushes:
evaluation by ambulatory monitoring Am J Obstet Gynecol.
1992;167:436-439.
Gandy S, Duff K. Post-menopausal estrogen deprivation and Alzheimer's
disease. Exp Gerontol. 2000;35(4):503-511.
Gardner C. Ease through menopause with homeopathic and herbal medicine. J
Perianesth Nurs. 1999;14(3):139-143.
Giardina EG. Heart disease in women. Int J Fertil Womens Med.
2000;45(6):350-357.
Glazier MG, Bowman MA. A review of the evidence for the use of phytoestrogens
as a replacement for traditional estrogen replacement therapy. Arch Intern
Med. 2001;161(9):1161-1172.
Greene RA. Estrogen and cerebral blood flow: a mechanism to explain the
influence of estrogen on the incidence and treatment of Alzheimer's disease.
Int J Fertil Womens Med. 2000;45(4):253-257.
Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the
risk of colorectal cancer: a review a meta-analysis.Am J Med.
1999;106(5):574-582.
Hammar M, Berg G, Lindgren R. Does physical exercise influence the frequency
of postmenopausal hot flushes? Acta Obstet Gynecol Scand.
1990;69(5):409-412.
Haggans CJ, Hutchins AM, Olson BM, et al. Effect of flaxseed consumption on
urinary estrogen metabolites in postmenopausal women. Nutr Cancer.
1999;33(2):188-195.
Heller HJ, Stewart A, Haynes S, et al. Pharmacokinetics of calcium absorption
from two commercial calcium supplements. J Clin Pharmacol.
1999;39:1151-1154.
Hirata JD, Swiersz LM, Zell B, et al. Does dong quai have estrogenic effects
in postmenopausal women? a double-blind, placebo controlled trial. Fertil
Steril. 1997;68(6):981-986.
Howes JB, Sullivan D, Lai N. The effects of dietary supplementation with
isoflavones from red clover on the lipoprotein profiles of post menopausal women
with mild to moderate hypercholesterolaemia. Atherosclerosis.
2000;152:143-147.
Irvin JH, Domar AD, Clark C, et. al. The effects of relaxation response
training on menopausal symptoms. J Psychosom Obstet Gynecol.
1996;17:202-207.
Iwamoto I, Kosha S, Noguchi S, et al. A longitudinal study of the effect of
vitamin K2 on bone mineral density in postmenopausal women a comparative study
with vitamin D3 and estrogen-progestin therapy. Maturitas.
1999;31:161-164.
Jeri AR. The effect of isoflavones phytoestrogens in relieving hot flushes in
Peruvian postmenopausal women. Paper presented at: 9th International
Menopause Society World Congress on the Menopause; October 20, 1999; Yokahama,
Japan.
Kass-Annese B. Alternative therapies for menopause. Clin Obstet Gynecol.
2000;43(1):162-183.
Kelley GA. Exercise and regional bone mineral density in postmenopausal
women. Am�J Phys Med Rehabil. 1998;77:76-87.
Kuller LH, Simkin-Silverman LR, Wing RR, et al. Women's healthy lifestyle
project: a randomized clinical trial. Circulation. 2001;103:32.
LeBoff MS, Kohlmeier L, Hurwitz S, et al. Occult vitamin D deficiency in
postmenopausal US women with acute hip fracture. JAMA.
1999;281:1505-1511.
Leveille SG, LaCroix AZ, Koepsell TD, et. al. Dietary vitamin C and bone
mineral density in postmenopausal women in Washington State, USA. J Epidemiol
Community Health. 1997;51:479-485.
Lianzhong W, Xiu Z. 300 cases of menopausal syndrome treated by acupuncture.
J Trad Chin Med. 1998;18(4):259-262.
Lieberman S. A review of the effectiveness of Cimicifuga racemosa
(black cohosh) for the symptoms of menopause. J Womens Health.
1998;7(5):525-529.
Liske E. Therapeutic efficacy and safety of Cimicifuga racemosa for
gynecologic disorders. Advances in Natural Therapy. 1998;75:45-53.
Loprinzi CL, Barton DL, Rhodes D. Management of hot flashes in breast-cancer
survivors. Lancet. 2001;2:199-204.
Lloyd T, Johnson-Rollings N, Eggli DF, et al. Bone status among
postmenopausal women with different habitual caffeine intakes: a longitudinal
investigation. J Am Coll Nutr. 2000;19(2):256-261.
Martin MC, Block JE, Sanchez SD, Arnaud DC, Beyene Y. Menopause without
symptoms: the endocrinology of menopause among rural Mayan Indians. Am J
Obstet Gynecol. 1993;168(6 Pt 1):1839-1843.
Masaki KH, Losonczy KG, Izmirlian G. Association of vitamin E and C
supplement use with cognitive function and dementia in elderly men.
Neurology. 2000;54:1265-1272.
Miszko TA, Cress ME. A lifetime of fitness, exercise in the perimenopausal
and postmenopausal woman. Clin Sports Med. 2000;19:215-231.
Mora S, Kershner DW, Vigilance CP, Blumenthal RS. Coronary artery disease in
postmenopausal women. Curr Treat Options Cardiovasc Med. 2001;3(1):67-79.
Morris MC, Beckett LA, Scherr PA, et al. Vitamin E and vitamin C supplement
use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord.
1998;12:121-126.
Muneyyirci-Delale O, Nacharaju VL, Dalloul M, Altura BM, Altura BT. Serum
ionized magnesium and calcium in women after menopause: Inverse relation of
estrogen with ionized magnesium. Fertil Steril. 1999;71:869-872.
Murkies AL, Lombard C, Strauss BJG, et al. Dietary flour supplementation
decreases post-menopausal hot flushes: effect of soy and wheat.
Maturitas. 1995;21:189-195.
NAMS Consensus. Consensus Opinion: the role of isoflavones in menopausal
health: consensus opinion of the North American Menopause Society.
Menopause. 2000;7(4):215-229.
NAMS Consensus. Consensus Opinion: the role of calcium in peri-and
postmenopausal women: consensus opinion of The North American Menopause Society.
Menopause. 2001;8(20):84-95.
Nachtigall LE. Isoflavones in the management of menopause. J Br Meno
Soc. 2001;suppl S1:8-12.
Nestel PJ, Pomeroy S, Kay S. Isoflavones from red clover improve systemic
arterial compliance by not plasma lipids in menopausal women. J Clin
Endocrinol Metab. 1999;84:895-898.
Nielson FH. Studies on the relationship between boron and magnesium which
possibly affects the formation and maintenance of bones. Magnesium Trace
Elem. 1990;9:61-69.
Nieves JW, Komar L, Cosman F, et al. Calcium potentiates the effect of
estrogen and calcitonin on bone mass: review and analysis. Am J Clin
Nutr. 1998;67:18-24.
Pepping J. Alternative therapies: black cohosh: Cimicifuga racemosa.
Am J Health-Syst Pharm. 1999;56:1400-1402.
Potter SM, Baum JA, Teng H, et al. Soy protein and isoflavones: their effects
on blood lipids and bone density in postmenopausal women. Am J Clin Nutr.
1998;68(s):1372s-1379s.
Qureshi IA. Ocular hypertensive effect of menopause with and without systemic
hypertension. Acta Obstet Gynecol Scand. 1996;75(3):266-269.
Reaven GM, Abasi F, Bernhart S, et al. Insulin resistance, dietary
cholesterol, and cholesterol concentration in postmenopausal women.
Metabolism. 2001;50(5):594-597.
Ruml LA, Sakhaee K, Peterson R, et al. The effect of calcium citrate on bone
density in the early and mid-postmenopausal period: a randomized placebo
controlled study. Am J Ther. 1999;6:303-311.
Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegiline,
alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J
Med. 1997;336:1216-1222.
Sator MO, Akramian J, Joura EA, et al. Reduction of intraocular pressure in a
glaucoma patient undergoing hormone replacement therapy. Maturitas.
1998;29(1):93-95.
Simkin-Silverman LR, Wing RR. Weight gain during menopause. Is it inevitable
or can it be prevented? Postgrad Med. 2000;108(3):47-50, 53-56.
Simon JA, Hsia J, Cauley, JA, Richards C, Harris F, Fong J, et al.
Postmenopausal hormone therapy and risk of stroke: The Heart and
Estrogen-progestin Replacement Study (HERS). Circulation.
2001;103(5):638-642.
Slaven L, Lee C. Mood and symptom reporting among middle-aged women: the
relationship between menopausal status, hormone replacement therapy, and
exercise participation. Health Psychol. 1997;16(3):203-208.
Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and
age-related macular degeneration: results from the Blue Mountains Eye Study.
Aust N Z J Opthalmol. 1997;25(Suppl 1):S13-S15.
Somekawa Y, Chiguchi M, Ishibashi T, et al. Soy intake related to menopausal
symptoms, serum lipids, and bone mineral density in postmenopausal Japanese
women. Obstet Gynecol. 2001;97:109-115.
Stark KD, Park EJ, Maines VA, et. al. Effect of a fish-oil concentrate on
serum lipids in postmenopausal women receiving and not receiving hormone
replacement therapy in a placebo-controlled, double-blind trial. Am J Clin
Nutr. 2000;72:389-394.
Taylor M. Alternatives to conventional hormone replacement therapy. Compr
Ther. 1997;23(8):514-532.
Tode T, Kikuchi Y, Hirata J, et. al. Effect of Korean red ginseng on
psychological functions in patients with severe climacteric syndromes. Int J
Gynaecol Obstet. 1999;67:169-174.
Umland EM, Cauffield JS, Kirk JK, et al. Phytoestrogens as therapeutic
alternatives to traditional hormone replacement in postmenopausal women.
Pharmacotherapy. 2000; 20(8)981-990.
Vincent A, Fitzpatrick LA. Soy isoflavones: are they useful in menopause?
Mayo Clin Proc. 2000;75:1174-1184.
Vingerling JR, Dielemans I, Witteman JCM, Hofman A, Grobbee DE, de Jong P.
Macular degeneration and early menopause: a case-control study. BMJ.
1995;310:1570-1571.
Wiklund IK, Mattsson LA, Lindgren R, et. al. Effects of a standardized
ginseng extract on quality of life and physiological parameters in symptomatic
postmenopausal women: a double-blind, placebo-controlled trial. Int J Clin
Pharm Res. 1999;XIX(3):89-99.
Wise P, Dubal D, Wilson M, Rau S, Bottner M. Minireview: Neuroprotective
effects of estrogen—new insights into the mechanisms of
action. Endocrinology. 2001;142(3):969-973.
Wyon Y, Lindgren R, Hammar M, Lundberg T. Acupuncture against climateric
disorders? Lower number of symptoms after menopause. Lakartidningen.
1994;91(23):2318-2322.
Yochum LA, Folsom AR, Kushi LH. Intake of antioxidant vitamins and risk of
death from stroke in postmenopausal women. Am J Clin Nutr.
2000;72:476-483.
Zell B, Hirata J, Marcus A, et al. Diagnosis of symptomatic postmenopausal
women by Traditional Chinese Medicine practitioners. Menopause.
2000;7:129-134.
Zhang Y, Felson DT, Ellison RC, et al. Bone mass and the risk of colon cancer
among postmenopausal women in the Framingham study. Am J Epidemiol.
2001;153(1):31-37.
|
|
| Review Date: June 2001 |
Reviewed By: Participants in the review process include: Ruth Debusk, RD, PhD, Editor,
Nutrition in Complementary Care, Tallahassee, FL; Jacqueline A. Hart, MD,
Department of Internal Medicine, Newton-Wellesley Hospital, Harvard University
and Senior Medical Editor Integrative Medicine, Boston, MA;�Lonnie Lee, MD,
Internal Medicine, Silver Springs, MD; Dana Ullman, MPH, Homeopathic Educational
Services, Berkeley, CA.
|
|
Copyright © 2002 A.D.A.M., Inc
|
| |
|